Roivant Sciences Ltd. Annual Income Tax Expense (Benefit) in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Roivant Sciences Ltd. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2020 to 2023.
  • Roivant Sciences Ltd. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $12.5M, a 285% increase year-over-year.
  • Roivant Sciences Ltd. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $42.3M, a 955% increase year-over-year.
  • Roivant Sciences Ltd. annual Income Tax Expense (Benefit) for 2023 was $22.2M, a 328% increase from 2022.
  • Roivant Sciences Ltd. annual Income Tax Expense (Benefit) for 2022 was $5.19M, a 1307% increase from 2021.
  • Roivant Sciences Ltd. annual Income Tax Expense (Benefit) for 2021 was $369K, a 78.1% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $22.2M +$17M +328% Apr 1, 2023 Mar 31, 2024 10-K 2024-05-30
2022 $5.19M +$4.82M +1307% Apr 1, 2022 Mar 31, 2023 10-K 2024-05-30
2021 $369K -$1.32M -78.1% Apr 1, 2021 Mar 31, 2022 10-K 2023-06-28
2020 $1.69M Apr 1, 2020 Mar 31, 2021 10-K 2022-06-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.